Cardiopulmonary performance diagnostics in patients 6 months after proven infection with SARS-CoV2 (COVID-19)
- Conditions
- 07.1 COVID-19
- Registration Number
- DRKS00023834
- Lead Sponsor
- Franzen Institut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Consent signed, clinically proven infection with SARS-CoV2
Exclusion Criteria
Persons who are under 18 years of age or over 80 years of age, who have an acute infection of the respiratory tract, who have another disease that prohibits heavy physical exertion, who have had a heart transplant, who have had heart surgery, who have had a heart attack, who have a congenital heart defect, who have had a lung transplant, who have reinfected themselves with iSARS-Cov2, who have poor German language skills, pregnant women, nursing mothers or who have not given written consent.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ew changes in spiroergometry/body plethysmography 6 months after detected COVID infection
- Secondary Outcome Measures
Name Time Method Persistent reduction of FVC and FEV1<br>Reduction of VO2max